Wired for Hope

Approximately 5 000 people in the United States are diagnosed with ALS each year, contributing to an estimated 300 000 individuals living with the disease worldwide. There is currently no cure. Jake Schneider’s involvement in Neuralink’s trials not only improves his own quality of life; it advances a technology that could one day benefit millions of people facing similar neurological challenges.

You can join this mission in several ways:

Together we can accelerate the pace of innovation and help transform the lives of people living with ALS. Your support, advocacy and willingness to learn make a tangible difference in building a future where neurological barriers no longer limit human potential.